` SHL (Sonic Healthcare Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

SHL
vs
S&P/ASX 300

Over the past 12 months, SHL has underperformed S&P/ASX 300, delivering a return of 3% compared to the S&P/ASX 300's 7% growth.

Stocks Performance
SHL vs S&P/ASX 300

Loading

Performance Gap
SHL vs S&P/ASX 300

Loading
SHL
S&P/ASX 300
Difference

Performance By Year
SHL vs S&P/ASX 300

Loading
SHL
S&P/ASX 300
Add Stock

Competitors Performance
Sonic Healthcare Ltd vs Peers

Sonic Healthcare Ltd
Glance View

Economic Moat
None
Market Cap
12.6B AUD
Industry
Health Care

Sonic Healthcare Ltd. began its journey in 1987, carved from a niche of independent pathology practices in Australia. It swiftly evolved into a global player, embracing a model that combines local expertise with the strength of an international network. The heart of Sonic's operations lies in its robust diagnostic services. Its laboratories process millions of tests each year, ensuring timely and accurate results across a spectrum of medical diagnostics, including pathology, radiology, and general practice medicine. This core service is augmented by state-of-the-art technology and a commitment to quality care, which has earned Sonic a reputation for reliability and excellence in the healthcare sector. Financially, Sonic Healthcare thrives on a business model that capitalizes on high volume and steady demand for medical diagnostic services. The company generates revenue through contracts with hospitals, clinics, and governments, providing essential health services that are non-discretionary and resilient, even in economic downturns. Growth is driven by strategic acquisitions and partnerships, which expand its footprint across regions like North America and Europe, ensuring a stream of diversified income. As healthcare spending continues to rise globally, Sonic Healthcare's business model remains well-positioned to leverage its international presence and expertise in diagnostic excellence, fueling sustainable growth and shareholder value over the long term.

SHL Intrinsic Value
34.69 AUD
Undervaluation 24%
Intrinsic Value
Price
Back to Top